Latest available resultsQuarter ended June 30, 202610-Q · August 5, 2026
Filed with the SECCVS HEALTH Corp
CVSConsumer & retail
Next reportOctober 27, 2026pre-market · Analyst forecast 1.628 $/share
Revenue
$106.10B
▲ +7.3% vs prior year% YoY
Net income
$2.98B
▲ +191.8% vs prior year% YoY
EPS
2.31$
▲ +188.8% vs prior year% YoY
Net margin
2.8%
▲ +1.8 percentage points vs prior year pp YoY
Revenue▲ +7.3 %
Margins (% of revenue)GrossOperatingNet
Net income▲ +191.8 %
EPS▲ +188.8 %
View financial tableQuarter ended June 30, 2026
| Metric | Value | Context |
|---|---|---|
| Operations | ||
| Revenue | $106.10B | |
| Gross profit | $47.23B | 44.5 % |
| Operating income | $4.70B | 4.4 % |
| Net income | $2.98B | 2.8 % |
| R&D | — | never filed |
| EPS (diluted) | 2.31 $ | |
| Balance sheet | ||
| Assets | $253.77B | |
| Liabilities | $173.87B | |
| Equity | $79.90B | |
| Cash | $11.33B | |
| Capital | ||
| Shares outstanding | 1.28B | as of 2026-07-29 |
| Public float | — | |